One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2-Reference-Cited by-同舟云学术

One-year maintenance outcomes among patients with moderately-to-severely active ulcerative colitis who responded to induction therapy with adalimumab: subgroup analyses from ULTRA 2

Published:2012-11-23 Issue:2 Volume:37 Page:204-213
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Sandborn W. J.¹,Colombel J.-F.²,D'Haens G.,Van Assche G.,Wolf D.³,Kron M.⁴,Lazar A.⁴,Robinson A. M.⁵,Yang M.⁵,Chao J. D.⁵,Thakkar R.⁵

Affiliation:

1. University of California San Diego; La Jolla; CA; USA

2. Centre Hospitalier Universitaire de Lille; Lille; France

3. Atlanta Gastroenterology Associates; Atlanta; GA; USA

4. Abbott GmbH & Co. KG; Ludwigshafen; Germany

5. Abbott Laboratories; Abbott Park; IL; USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.12145/fullpdf

Reference21 articles.

1. Ulcerative colitis;Ordás;Lancet,2012

2. Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology. Practice Parameters Committee;Kornbluth;Am J Gastroenterol,2010

3. Adalimumab for induction of clinical remission in moderately to severely active ulcerative colitis: results of a randomised controlled trial;Reinisch;Gut,2011

4. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis;Sandborn;Gastroenterology,2012

Cited by 118 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Saudi consensus guidance for the diagnosis and management of inflammatory bowel disease in children and adolescents;Saudi Journal of Gastroenterology;2024-08-30

2. It’s Time to Change Tack in IBD Treatment;Gastroenterology;2024-07

3. C-reactive protein-to-albumin ratio and neutrophil-to-albumin ratio for predicting response and prognosis to infliximab in ulcerative colitis;Frontiers in Medicine;2024-03-12

4. An indirect comparison of efficacy including histologic assessment and safety in biologic therapy in ulcerative colitis: Systemic review and network meta-analysis;PLOS ONE;2023-11-02

5. Study of tumor necrosis factor receptor in the inflammatory bowel disease;World Journal of Gastroenterology;2023-05-14